Literature DB >> 32489816

Expression of transforming growth factor beta in oral submucous fibrosis.

Arpita Rai1,2, Tanveer Ahmad3, Shama Parveen1, Saba Parveen1, Md Imam Faizan3, Sher Ali1.   

Abstract

BACKGROUND: Oral submucous fibrosis (OSMF) is a premalignant condition mainly caused by areca nut chewing and is characterized by progressive fibrosis of submucosal tissues and epithelial atrophy. Activation of transforming growth factor beta (TGF-β) signaling is considered main causative event for increased collagen production and fibrosis. In this study, molecular pathogenesis of OSMF was investigated based on the expression of the TGF-β genes in OSMF tissues compared to normal controls.
METHODS: A total of 33 OSMF and 10 normal tissues were collected from patients and their clinic-epidemiological data was recorded. The expression of TGF-β isoform genes- TGF β1, TGF β2, TGF β3 and its receptor TGF βR1, TGF βR2 was studied by real time polymerase chain reaction (PCR). Comparison of the expression of these genes among normal controls and OSMF patients was done. The PCR results were confirmed by histopathological and immunohistochemical staining.
RESULTS: The histological changes included atrophic epithelium, loss of rete ridges, presence of inflammatory cells and dense collagen bundles in connective tissue. PCR showed statistically significant upregulation of TGF-β isoforms in OSMF as compared to normal tissues. Of the three isoforms, maximum fold change was observed in TGF-β1. Similarly, both TGF-βR1 and TGF-βR2 were found to be elevated in OSMF tissues compared to normal. The semi-quantitative analysis by immunohistochemical staining revealed statistically significant difference between normal and OSMF tissues.
CONCLUSION: TGF-β signaling plays a major role in the molecular pathogenesis of OSMF as shown by increased mRNA expression of all the three TGF-β isotypes and their receptors.
© 2020 Craniofacial Research Foundation. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Oral submucous fibrosis; Polymerase chain reaction; TGF-β; TGF-β isoforms; TGF-β receptors; Transforming growth factor beta

Year:  2020        PMID: 32489816      PMCID: PMC7254463          DOI: 10.1016/j.jobcr.2020.03.015

Source DB:  PubMed          Journal:  J Oral Biol Craniofac Res        ISSN: 2212-4268


  23 in total

1.  [Expression of transforming growth factor beta 1 in keratinocytes of oral submucous fibrosis tissue].

Authors:  Y Gao; T Ling; H Wu
Journal:  Zhonghua Kou Qiang Yi Xue Za Zhi       Date:  1997-07

Review 2.  Post-translational regulation of TGF-β receptor and Smad signaling.

Authors:  Pinglong Xu; Jianming Liu; Rik Derynck
Journal:  FEBS Lett       Date:  2012-05-19       Impact factor: 4.124

3.  Progression of precancerous lesions to oral cancer: results based on the Taiwan National Health Insurance Database.

Authors:  Ie-Bin Lian; Yao-Ting Tseng; Che-Chun Su; Kuo-Yang Tsai
Journal:  Oral Oncol       Date:  2012-12-27       Impact factor: 5.337

Review 4.  Areca nut in pathogenesis of oral submucous fibrosis: revisited.

Authors:  Punnya V Angadi; Sanjay S Rao
Journal:  Oral Maxillofac Surg       Date:  2011-03

5.  Evaluation of transforming growth factor beta1 gene in oral submucous fibrosis induced in Sprague-Dawley rats by injections of areca nut and pan masala (commercial areca nut product) extracts.

Authors:  Shilpa Maria; Venkatesh V Kamath; Krishnanand Satelur; Komali Rajkumar
Journal:  J Cancer Res Ther       Date:  2016 Jan-Mar       Impact factor: 1.805

6.  Role of areca nut induced JNK/ATF2/Jun axis in the activation of TGF-β pathway in precancerous Oral Submucous Fibrosis.

Authors:  Ila Pant; S Girish Rao; Paturu Kondaiah
Journal:  Sci Rep       Date:  2016-10-06       Impact factor: 4.379

7.  Expression of transforming growth factor β and its correlation with lipodystrophy in oral submucous fibrosis: an immunohistochemical study.

Authors:  Alka D Kale; Deepa R Mane; Deepika Shukla
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2013-01-01

8.  Activation of TGF-β pathway by areca nut constituents: a possible cause of oral submucous fibrosis.

Authors:  Imran Khan; Neeraj Kumar; Ila Pant; Sivakrishna Narra; Paturu Kondaiah
Journal:  PLoS One       Date:  2012-12-19       Impact factor: 3.240

9.  TGF-beta isoforms in renal fibrogenesis.

Authors:  Ling Yu; Wayne A Border; Yufeng Huang; Nancy A Noble
Journal:  Kidney Int       Date:  2003-09       Impact factor: 18.998

10.  Transforming growth factor-β1 and TGF-β2 act synergistically in the fibrotic pathway in oral submucous fibrosis: An immunohistochemical observation.

Authors:  Venkatesh Viswanath Kamath; Shruti Krishnamurthy; Krishnanand P Satelur; Komali Rajkumar
Journal:  Indian J Med Paediatr Oncol       Date:  2015 Apr-Jun
View more
  4 in total

Review 1.  The diverse role of oral fibroblasts in normal and disease.

Authors:  R J Vijayashree; B Sivapathasundharam
Journal:  J Oral Maxillofac Pathol       Date:  2022-03-31

2.  Small Molecule "Silmitasertib" Repurposed as Inhibitor of Transforming Growth Factor Beta 1 for the Development of Therapeutics for Oral Submucous Fibrosis.

Authors:  Nezar Boreak
Journal:  Biomed Res Int       Date:  2021-04-01       Impact factor: 3.411

Review 3.  Leaving no stone unturned: Role of profibrotic genes in oral submucous fibrosis - A systematic review.

Authors:  Amritha James; Lekshmy Jayan; Ramya Ramadoss; Preethi Arunachalam
Journal:  J Oral Maxillofac Pathol       Date:  2022-06-28

Review 4.  Oral Submucous Fibrosis: A Review on Biomarkers, Pathogenic Mechanisms, and Treatments.

Authors:  Yen-Wen Shen; Yin-Hwa Shih; Lih-Jyh Fuh; Tzong-Ming Shieh
Journal:  Int J Mol Sci       Date:  2020-09-30       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.